Amgen Inc. (AMGN) Q3 2011 Earnings Results

Amgen Beats on EPS, Stock Up 0.61%

Amgen's earnings report shows a positive surprise in EPS, which contributed to a slight increase in the stock price. The lack of revenue data and guidance may leave some investors cautious, but the EPS beat suggests the company is managing its costs effectively. The stock's modest gain reflects a generally favorable reception to the earnings news.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.40	N/A	+10.67%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's financial health. They highlighted the importance of maintaining a strong EPS as a positive indicator.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

They emphasized a focus on long-term growth strategies.

Amgen Beats on EPS, Stock Up 0.61%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Up 0.61%

Key numbers

Management commentary